Fundraising Fox
BioVersys
Basel, CH · Founded 2010 · 41 employees on LinkedIn · 3 known investors
Find your way into BioVersys
Sign up to find every way you can get introduced to BioVersys
- Your email: who you already know at BioVersys, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioVersys team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BioVersys is a clinical-stage biotech company focused on developing antimicrobial therapies to address unmet medical needs in infectious diseases, including tuberculosis and hospital-acquired infections. The company targets infectious disease indications with next-generation antimicrobial treatments.
Founders & leadership
BioVersys was founded in 2010 by Dr. Marc Gitzinger.
Investors · 3
How we know: AMR Action Fund's portfolio page · a partner's Signal profile · cidrap.umn.edu · funding news · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries C ExtensionMay 2024
GSK plc
Source ↗ - Undisclosed amountSeries C investment roundJan 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does BioVersys do?
- BioVersys is a clinical-stage biotech company focused on developing antimicrobial therapies to address unmet medical needs in infectious diseases, including tuberculosis and hospital-acquired infections. The company targets infectious disease indications with next-generation antimicrobial treatments.
- Who founded BioVersys?
- BioVersys was founded by Dr. Marc Gitzinger in 2010.
- Who are BioVersys's investors?
- BioVersys's investors include AMR Action Fund, StartAngels Network.
- Where is BioVersys headquartered?
- BioVersys is headquartered in Basel, CH.